Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and the gut: New developments and emerging concepts
Angelo A. Izzo, Keith A. Sharkey
Pharmacology & Therapeutics (2010) Vol. 126, Iss. 1, pp. 21-38
Closed Access | Times Cited: 396

Showing 1-25 of 396 citing articles:

A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
Nicholas R. Fuller, Stephen Colagiuri, Deborah Schofield, et al.
International Journal of Obesity (2012) Vol. 37, Iss. 6, pp. 828-834
Open Access | Times Cited: 2043
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou, Ujendra Kumar
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 3, pp. 833-833
Open Access | Times Cited: 1108
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone, Itai Bab, Tamás Bı́ró, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 5, pp. 277-296
Open Access | Times Cited: 595
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pál Pacher, Raphael Mechoulam
Progress in Lipid Research (2011) Vol. 50, Iss. 2, pp. 193-211
Open Access | Times Cited: 402
Modulating the endocannabinoid system in human health and disease – successes and failures
Pál Pacher, George Kunos
FEBS Journal (2013) Vol. 280, Iss. 9, pp. 1918-1943
Open Access | Times Cited: 369
Endocannabinoids — at the crossroads between the gut microbiota and host metabolism
Patrice D. Cani, Hubert Plovier, Matthias Van Hul, et al.
Nature Reviews Endocrinology (2015) Vol. 12, Iss. 3, pp. 133-143
Closed Access | Times Cited: 313
Cannabinoid Hyperemesis: A Case Series of 98 Patients
Douglas A. Simonetto, Amy S. Oxentenko, Margot L. Herman, et al.
Mayo Clinic Proceedings (2012) Vol. 87, Iss. 2, pp. 114-119
Open Access | Times Cited: 307
Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
John Bostwick
Mayo Clinic Proceedings (2012) Vol. 87, Iss. 2, pp. 172-186
Open Access | Times Cited: 250
The Role of the Endocannabinoid System in the Brain–Gut Axis
Keith A. Sharkey, John Wiley
Gastroenterology (2016) Vol. 151, Iss. 2, pp. 252-266
Open Access | Times Cited: 214
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Peter J. Kahrilas, Guy E. Boeckxstaens
Gastroenterology (2013) Vol. 145, Iss. 5, pp. 954-965
Open Access | Times Cited: 212
Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease
Martin Storr, Shane Devlin, Gilaad G. Kaplan, et al.
Inflammatory Bowel Diseases (2014) Vol. 20, Iss. 3, pp. 472-480
Closed Access | Times Cited: 194
Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …
Eric P. Baron
Headache The Journal of Head and Face Pain (2015) Vol. 55, Iss. 6, pp. 885-916
Open Access | Times Cited: 189
Probiotics, Prebiotics, and Phytogenic Substances for Optimizing Gut Health in Poultry
Awad A. Shehata, Sakine Yalçın, Juan D. Latorre, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 395-395
Open Access | Times Cited: 149
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
Vicente Martı́nez, Amaia Iriondo‐DeHond, Francesca Borrelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3067-3067
Open Access | Times Cited: 142
The Endocannabinoid System and Physical Exercise
Daniela Matei, Dan Trofin, Daniel Andrei Iordan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1989-1989
Open Access | Times Cited: 51
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale, Vincenzo Di Marzo, Alexandra Šulcová, et al.
Pharmacology & Therapeutics (2012) Vol. 138, Iss. 1, pp. 18-37
Closed Access | Times Cited: 202
Stress and visceral pain: From animal models to clinical therapies
Muriel Larauche, Agata Mulak, Yvette Taché
Experimental Neurology (2011) Vol. 233, Iss. 1, pp. 49-67
Open Access | Times Cited: 193
Endocannabinoid signal in the gut controls dietary fat intake
Nicholas V. DiPatrizio, Giuseppe Astarita, Gary J. Schwartz, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 31, pp. 12904-12908
Open Access | Times Cited: 184
Role of gut nutrient sensing in stimulating appetite and conditioning food preferences
Anthony Sclafani, Karen Ackroff
AJP Regulatory Integrative and Comparative Physiology (2012) Vol. 302, Iss. 10, pp. R1119-R1133
Open Access | Times Cited: 184
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
Keith A. Sharkey, Nissar A. Darmani, Linda A. Parker
European Journal of Pharmacology (2013) Vol. 722, pp. 134-146
Open Access | Times Cited: 182
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
Gabriella Aviello, Barbara Romano, Francesca Borrelli, et al.
Journal of Molecular Medicine (2012) Vol. 90, Iss. 8, pp. 925-934
Closed Access | Times Cited: 177
Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
Cecilia J. Hillard, Kenneth M. Weinlander, Kara L. Stuhr
Neuroscience (2011) Vol. 204, pp. 207-229
Open Access | Times Cited: 173
Cannabis use amongst patients with inflammatory bowel disease
Simon Lal, Neeraj Prasad, Manijeh Ryan, et al.
European Journal of Gastroenterology & Hepatology (2011) Vol. 23, Iss. 10, pp. 891-896
Closed Access | Times Cited: 166
Page 1 - Next Page

Scroll to top